Toolkit
Latest project information
HTA - 11/36/16
The Low Risk DCIS (ductal carcinoma in situ) Trial
Project title: The Low Risk DCIS (ductal carcinoma in situ) Trial
Call to action: 11/36 HTA Clinical Trials - November 2011 Board submission (May 2011 deadline)
Research type: Primary Research
Chief investigator: Dr Matthew Wallis
Contractor: University of Birmingham
Cost: £2,102,213.10
Co-investigators: Dr Daniel Rea, Dr David Dodwell, Dr Jeremy Thomas, Dr Sarah Bowden, Mrs Cassandra Brookes, Ms Maggie Wilcox, Professor Andrew Evans, Professor Andrew Hanby, Professor Dame Lesley Fallowfield, Professor John Bartlett, Professor Lucinda Billingham, Professor Malcolm Reed, Professor Sarah Pinder, Professor Tracy Roberts.
Started: April 2014 | Status: Research in progress
ISRCTN: 27544579
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.
Background & Research Questions
Why the research is being done and what is being asked
Methods
How the research is being done
Publications & Outputs
What the research produced
Outcomes & Impact
What happened as a result of the research